Magazine

"Make-or-Break Time for Cancer Drugs" (Personal Business, June 8, 2009)


"Make-or-Break Time for Cancer Drugs" (Personal Business, June 8, 2009) mistakenly said that biotech company Celgene has a forthcoming treatment for hepatitis C. Celgene is not focusing on this disease.


Best LBO Ever
LIMITED-TIME OFFER SUBSCRIBE NOW
 
blog comments powered by Disqus